Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Epidemiological, Molecular, and Clinical Features of Norovirus Infections among Pediatric Patients in Qatar.

Mathew S, Alansari K, K Smatti M, Zaraket H, Al Thani AA, Yassine HM.

Viruses. 2019 Apr 29;11(5). pii: E400. doi: 10.3390/v11050400.

2.

Seasonal influenza vaccination policies in the Eastern Mediterranean Region: Current status and the way forward.

Abubakar A, Melhem N, Malik M, Dbaibo G, Khan WM, Zaraket H.

Vaccine. 2019 Mar 14;37(12):1601-1607. doi: 10.1016/j.vaccine.2019.02.001. Epub 2019 Feb 19.

3.

Detection of ON1 and novel genotypes of human respiratory syncytial virus and emergence of palivizumab resistance in Lebanon.

Abou-El-Hassan H, Massaad E, Soudani N, Assaf-Casals A, Shaker R, Lteif Khoury M, Ghanem S, Karam M, Andary R, Saito R, Dbaibo G, Zaraket H.

PLoS One. 2019 Feb 21;14(2):e0212687. doi: 10.1371/journal.pone.0212687. eCollection 2019.

4.

Prevalence and characteristics of acute respiratory virus infections in pediatric cancer patients.

Soudani N, Caniza MA, Assaf-Casals A, Shaker R, Lteif M, Su Y, Tang L, Akel I, Muwakkit S, Chmaisse A, Homsi M, Dbaibo G, Zaraket H.

J Med Virol. 2019 Jul;91(7):1191-1201. doi: 10.1002/jmv.25432. Epub 2019 Feb 27.

PMID:
30763464
5.

Ceramide Suppresses Influenza A Virus Replication In Vitro.

Soudani N, Hage-Sleiman R, Karam W, Dbaibo G, Zaraket H.

J Virol. 2019 Mar 21;93(7). pii: e00053-19. doi: 10.1128/JVI.00053-19. Print 2019 Apr 1.

PMID:
30700605
6.

Phylogeographic analysis of human influenza A and B viruses in Myanmar, 2010-2015.

Htwe KTZ, Dapat C, Shobugawa Y, Odagiri T, Hibino A, Kondo H, Yagami R, Saito T, Takemae N, Tamura T, Watanabe H, Kyaw Y, Lin N, Myint YY, Tin HH, Thein W, Kyaw LL, Soe PE, Naito M, Zaraket H, Suzuki H, Abe T, Saito R.

PLoS One. 2019 Jan 10;14(1):e0210550. doi: 10.1371/journal.pone.0210550. eCollection 2019.

7.

Review of seasonal influenza vaccination in the Eastern Mediterranean Region: Policies, use and barriers.

Zaraket H, Melhem N, Malik M, Khan WM, Dbaibo G, Abubakar A.

J Infect Public Health. 2019 Jul - Aug;12(4):472-478. doi: 10.1016/j.jiph.2018.10.009. Epub 2018 Nov 13.

8.

Incidence of antiviral drug resistance markers among human influenza A viruses in the Eastern Mediterranean Region, 2005-2016.

Moasser E, Moasser A, Zaraket H.

Infect Genet Evol. 2019 Jan;67:60-66. doi: 10.1016/j.meegid.2018.10.023. Epub 2018 Oct 30.

PMID:
30389548
9.

Influenza vaccination situation in Middle-East and North Africa countries: Report of the 7th MENA Influenza Stakeholders Network (MENA-ISN).

7th MENA-ISN study group, Al Awaidi S, Abusrewil S, AbuHasan M, Akcay M, Aksakal FNB, Bashir U, Elahmer O, Esteghamati A, Gahwagi M, Mirza YK, Grasso C, Kassianos G, Khris M, Mardani M, Maltezou H, Nourlil J, Oumzil H, Osterhaus A, Picot V, Pehlivan T, Saadatian-Elahi M, Tali İ, Tarraf H, Ugur B, Zaraket H; List of authors is in alphabetical order.

J Infect Public Health. 2018 Nov - Dec;11(6):845-850. doi: 10.1016/j.jiph.2018.07.003. Epub 2018 Aug 17.

10.

Diagnostic tools of caprine and ovine anaplasmosis: a direct comparative study.

Shabana II, Alhadlag NM, Zaraket H.

BMC Vet Res. 2018 May 22;14(1):165. doi: 10.1186/s12917-018-1489-x.

11.

Complete Genome Sequence of an ON1 Human Respiratory Syncytial Virus Strain Isolated in Lebanon in 2015.

Ezzeddine A, Soudani N, Lee CK, Dbaibo G, Elbahesh H, Zaraket H.

Genome Announc. 2018 Apr 19;6(16). pii: e00316-18. doi: 10.1128/genomeA.00316-18.

12.

Neuraminidase inhibitor susceptibility and evolutionary analysis of human influenza B isolates from three Asian countries during 2012-2015.

Hibino A, Massaad E, Kondo H, Saito R, Odagiri T, Takemae N, Tsunekuni R, Saito T; Japanese Influenza Collaborative Study Group, Kyaw Y, Lin N, Myint YY, Tin HH, Le Khanh Hang N, Mai LQ, Yagami R, Shobugawa Y, Lam T, Zaraket H.

Infect Genet Evol. 2018 Aug;62:27-33. doi: 10.1016/j.meegid.2018.04.016. Epub 2018 Apr 14.

13.

Pityriasis rosea-like eruption associated with ondansetron use in pregnancy.

Alame MM, Chamsy DJ, Zaraket H.

Br J Clin Pharmacol. 2018 May;84(5):1077-1080. doi: 10.1111/bcp.13560. Epub 2018 Mar 9.

14.

Molecular epidemiology of human respiratory syncytial virus among children in Japan during three seasons and hospitalization risk of genotype ON1.

Hibino A, Saito R, Taniguchi K, Zaraket H, Shobugawa Y, Matsui T, Suzuki H; Japanese HRSV Collaborative Study Group.

PLoS One. 2018 Jan 29;13(1):e0192085. doi: 10.1371/journal.pone.0192085. eCollection 2018.

15.

Characterization of the neuraminidase genes from human influenza A viruses circulating in Iran from 2010 to 2015.

Moasser E, Behzadian F, Moattari A, Fotouhi F, Zaraket H.

Arch Virol. 2018 Feb;163(2):391-400. doi: 10.1007/s00705-017-3603-y. Epub 2017 Oct 31.

PMID:
29086107
16.

Update on the epidemiology of rotavirus in the Middle East and North Africa.

Zaraket H, Charide R, Kreidieh K, Dbaibo G, Melhem NM.

Vaccine. 2017 Oct 27;35(45):6047-6058. doi: 10.1016/j.vaccine.2017.09.067. Epub 2017 Oct 3. Review.

PMID:
28986034
17.

Characterization of astrovirus-associated gastroenteritis in hospitalized children under five years of age.

Zaraket H, Abou-El-Hassan H, Kreidieh K, Soudani N, Ali Z, Hammadi M, Reslan L, Ghanem S, Hajar F, Inati A, Rajab M, Fakhouri H, Ghanem B, Baasiri G, Melhem NM, Dbaibo G.

Infect Genet Evol. 2017 Sep;53:94-99. doi: 10.1016/j.meegid.2017.05.016. Epub 2017 May 20.

PMID:
28536072
18.

Global epidemiology of non-influenza RNA respiratory viruses: data gaps and a growing need for surveillance.

Tang JW, Lam TT, Zaraket H, Lipkin WI, Drews SJ, Hatchette TF, Heraud JM, Koopmans MP; INSPIRE investigators.

Lancet Infect Dis. 2017 Oct;17(10):e320-e326. doi: 10.1016/S1473-3099(17)30238-4. Epub 2017 Apr 28. Review. Erratum in: Lancet Infect Dis. 2017 Jul;17(7):689.

19.

Molecular characterization and phylogenetic analysis of human influenza A viruses isolated in Iran during the 2014-2015 season.

Moasser E, Behzadian F, Moattari A, Fotouhi F, Rahimi A, Zaraket H, Hosseini SY.

Arch Virol. 2017 Jul;162(7):1975-1984. doi: 10.1007/s00705-017-3323-3. Epub 2017 Mar 22.

PMID:
28331993
20.

Clinical and epidemiological characteristics of norovirus gastroenteritis among hospitalized children in Lebanon.

Melhem NM, Zaraket H, Kreidieh K, Ali Z, Hammadi M, Ghanem S, Hajar F, Haidar A, Inati A, Rajab M, Fakhouri H, Ghanem B, Baasiri G, Dbaibo G.

World J Gastroenterol. 2016 Dec 28;22(48):10557-10565. doi: 10.3748/wjg.v22.i48.10557.

21.

Japanese Surveillance Systems and Treatment for Influenza.

Zaraket H, Saito R.

Curr Treat Options Infect Dis. 2016;8(4):311-328. doi: 10.1007/s40506-016-0085-5. Epub 2016 Oct 10. Review.

22.

Viral-derived complement inhibitors: current status and potential role in immunomodulation.

Abou-El-Hassan H, Zaraket H.

Exp Biol Med (Maywood). 2017 Feb;242(4):397-410. doi: 10.1177/1535370216675772. Epub 2016 Oct 26. Review.

23.

Complete Genome Sequence of the First H5N1 Avian Influenza Virus Isolated from Chickens in Lebanon in 2016.

Ibrahim E, Sirawan A, El-Bazzal B, El Hage J, Abi Said M, Zaraket H, Kandeil A, Ali MA, Kayali G.

Genome Announc. 2016 Oct 20;4(5). pii: e01062-16. doi: 10.1128/genomeA.01062-16.

24.

Characterization of influenza outbreaks in Lebanon during the 2013/14 and 2014/15 seasons.

Saito R, Akinobu H, Shaker RA, Akel IS, Assaf-Casals A, Lteif M, Odagiri T, Inaba R, Soudani N, Khafaja S, Ghanem ST, Rajab M, Shobugawa Y, Dbaibo GS, Zaraket H.

East Mediterr Health J. 2016 Oct 2;22(7):547-551.

PMID:
27714749
25.

Community- and hospital-acquired infections with oseltamivir- and peramivir-resistant influenza A(H1N1)pdm09 viruses during the 2015-2016 season in Japan.

Hibino A, Kondo H, Masaki H, Tanabe Y, Sato I, Takemae N, Saito T, Zaraket H, Saito R.

Virus Genes. 2017 Feb;53(1):89-94. doi: 10.1007/s11262-016-1396-9. Epub 2016 Oct 6.

26.

Rotavirus Genotypes and Vaccine Effectiveness from a Sentinel, Hospital-Based, Surveillance Study for Three Consecutive Rotavirus Seasons in Lebanon.

Ali Z, Harastani H, Hammadi M, Reslan L, Ghanem S, Hajar F, Sabra A, Haidar A, Inati A, Rajab M, Fakhouri H, Ghanem B, Baasiri G, Gerbaka B, Zaraket H, Matar GM, Dbaibo G.

PLoS One. 2016 Aug 29;11(8):e0161345. doi: 10.1371/journal.pone.0161345. eCollection 2016.

27.

Peramivir: A Novel Intravenous Neuraminidase Inhibitor for Treatment of Acute Influenza Infections.

Alame MM, Massaad E, Zaraket H.

Front Microbiol. 2016 Mar 31;7:450. doi: 10.3389/fmicb.2016.00450. eCollection 2016. Review.

28.

Full Genome Characterization of Human Influenza A/H3N2 Isolates from Asian Countries Reveals a Rare Amantadine Resistance-Conferring Mutation and Novel PB1-F2 Polymorphisms.

Zaraket H, Kondo H, Hibino A, Yagami R, Odagiri T, Takemae N, Tsunekuni R, Saito T; Japanese Influenza Collaborative Study Group, Myint YY, Kyaw Y, Oo KY, Tin HH, Lin N, Anh NP, Hang Nle K, Mai le Q, Hassan MR, Shobugawa Y, Tang J, Dbaibo G, Saito R.

Front Microbiol. 2016 Mar 7;7:262. doi: 10.3389/fmicb.2016.00262. eCollection 2016.

29.

Influenza and its treatment during pregnancy: A review.

Ghulmiyyah LM, Alame MM, Mirza FG, Zaraket H, Nassar AH.

J Neonatal Perinatal Med. 2015;8(4):297-306. doi: 10.3233/NPM-15814124. Review.

PMID:
26836818
30.

Mammalian adaptation of influenza A(H7N9) virus is limited by a narrow genetic bottleneck.

Zaraket H, Baranovich T, Kaplan BS, Carter R, Song MS, Paulson JC, Rehg JE, Bahl J, Crumpton JC, Seiler J, Edmonson M, Wu G, Karlsson E, Fabrizio T, Zhu H, Guan Y, Husain M, Schultz-Cherry S, Krauss S, McBride R, Webster RG, Govorkova EA, Zhang J, Russell CJ, Webby RJ.

Nat Commun. 2015 Apr 8;6:6553. doi: 10.1038/ncomms7553.

31.

Characterization of human Influenza Viruses in Lebanon during 2010-2011 and 2011-2012 post-pandemic seasons.

Zaraket H, Dapat C, Ghanem S, Ali Z, Lteif M, Kondo H, Dapat IC, Saito K, Kayali G, Suzuki H, Dbaibo G, Saito R.

Intervirology. 2014;57(6):344-52. doi: 10.1159/000365758. Epub 2014 Oct 3.

32.

Epistatic interactions between neuraminidase mutations facilitated the emergence of the oseltamivir-resistant H1N1 influenza viruses.

Duan S, Govorkova EA, Bahl J, Zaraket H, Baranovich T, Seiler P, Prevost K, Webster RG, Webby RJ.

Nat Commun. 2014 Oct 9;5:5029. doi: 10.1038/ncomms6029.

33.

Characterization of an H4N2 influenza virus from Quails with a multibasic motif in the hemagglutinin cleavage site.

Wong SS, Yoon SW, Zanin M, Song MS, Oshansky C, Zaraket H, Sonnberg S, Rubrum A, Seiler P, Ferguson A, Krauss S, Cardona C, Webby RJ, Crossley B.

Virology. 2014 Nov;468-470:72-80. doi: 10.1016/j.virol.2014.07.048. Epub 2014 Aug 23.

34.

Proteolytic enzymes in embryonated chicken eggs sustain the replication of egg-grown low-pathogenicity avian influenza viruses in cells in the absence of exogenous proteases.

Kandeil A, Bagato O, Zaraket H, Debeauchamp J, Krauss S, El-Shesheny R, Webby RJ, Ali MA, Kayali G.

J Virol Methods. 2014 Jun;202:28-33. doi: 10.1016/j.jviromet.2014.02.023. Epub 2014 Mar 10.

35.

Molecular studies on diarrhea-associated Escherichia coli isolated from humans and animals in Egypt.

Shabana II, Zaraket H, Suzuki H.

Vet Microbiol. 2013 Dec 27;167(3-4):532-9. doi: 10.1016/j.vetmic.2013.08.014. Epub 2013 Aug 29.

PMID:
24051128
36.

Human H7N9 influenza A viruses replicate in swine respiratory tissue explants.

Jones JC, Baranovich T, Zaraket H, Guan Y, Shu Y, Webby RJ, Webster RG.

J Virol. 2013 Nov;87(22):12496-8. doi: 10.1128/JVI.02499-13. Epub 2013 Sep 11.

37.

Fecal influenza in mammals: selection of novel variants.

Koçer ZA, Obenauer J, Zaraket H, Zhang J, Rehg JE, Russell CJ, Webster RG.

J Virol. 2013 Nov;87(21):11476-86. doi: 10.1128/JVI.01544-13. Epub 2013 Aug 21.

38.

Increased acid stability of the hemagglutinin protein enhances H5N1 influenza virus growth in the upper respiratory tract but is insufficient for transmission in ferrets.

Zaraket H, Bridges OA, Duan S, Baranovich T, Yoon SW, Reed ML, Salomon R, Webby RJ, Webster RG, Russell CJ.

J Virol. 2013 Sep;87(17):9911-22. doi: 10.1128/JVI.01175-13. Epub 2013 Jul 3.

39.

The pH of activation of the hemagglutinin protein regulates H5N1 influenza virus replication and pathogenesis in mice.

Zaraket H, Bridges OA, Russell CJ.

J Virol. 2013 May;87(9):4826-34. doi: 10.1128/JVI.03110-12. Epub 2013 Feb 28.

40.

Molecular epidemiology of methicillin-resistant Staphylococcus aureus isolated from children in a community with low antimicrobial pressure in Japan.

Otsuka T, Zaraket H, Fujii K, Masuda Y, Komiyama K, Ishikawa Y, Shirai T, Iwaya A, Okazaki M.

Jpn J Infect Dis. 2012;65(6):483-8.

41.

Acid stability of the hemagglutinin protein regulates H5N1 influenza virus pathogenicity.

DuBois RM, Zaraket H, Reddivari M, Heath RJ, White SW, Russell CJ.

PLoS Pathog. 2011 Dec;7(12):e1002398. doi: 10.1371/journal.ppat.1002398. Epub 2011 Dec 1.

42.

Genotyping of Haemophilus influenzae type b in pre-vaccination era.

Otsuka T, Komiyama K, Yoshida K, Ishikawa Y, Zaraket H, Fujii K, Okazaki M.

J Infect Chemother. 2012 Apr;18(2):213-8. doi: 10.1007/s10156-011-0323-1. Epub 2011 Oct 25.

PMID:
22038124
43.

Prevalence of methicillin-resistant Staphylococcus aureus among children in a region with controlled antimicrobial use.

Otsuka T, Yoshida K, Komiyama K, Ishikawa Y, Zaraket H, Okazaki M.

Jpn J Infect Dis. 2011;64(5):436-8.

44.

Genetic diversity and antiviral drug resistance of pandemic H1N1 2009 in Lebanon.

Zaraket H, Kondo H, Tabet C, Hanna-Wakim R, Suzuki Y, Dbaibo GS, Saito R, Suzuki H.

J Clin Virol. 2011 Jul;51(3):170-4. doi: 10.1016/j.jcv.2011.04.001. Epub 2011 May 11.

PMID:
21565547
45.

Molecular characteristics of outbreaks of nosocomial infection with influenza A/H3N2 virus variants.

Oguma T, Saito R, Masaki H, Hoshino K, Zaraket H, Suzuki Y, Caperig-Dapat I, Dapat C, Baranovich T, Kuroki R, Makimoto Y, Shirahige Y, Asoh N, Degawa S, Ishikawa H, Kageura H, Hosoi M, Suzuki H.

Infect Control Hosp Epidemiol. 2011 Mar;32(3):267-75. doi: 10.1086/658671.

PMID:
21460512
46.

Identification of oseltamivir resistance among pandemic and seasonal influenza A (H1N1) viruses by an His275Tyr genotyping assay using the cycling probe method.

Suzuki Y, Saito R, Sato I, Zaraket H, Nishikawa M, Tamura T, Dapat C, Caperig-Dapat I, Baranovich T, Suzuki T, Suzuki H.

J Clin Microbiol. 2011 Jan;49(1):125-30. doi: 10.1128/JCM.01401-10. Epub 2010 Nov 17.

47.

New genotypes within respiratory syncytial virus group B genotype BA in Niigata, Japan.

Dapat IC, Shobugawa Y, Sano Y, Saito R, Sasaki A, Suzuki Y, Kumaki A, Zaraket H, Dapat C, Oguma T, Yamaguchi M, Suzuki H.

J Clin Microbiol. 2010 Sep;48(9):3423-7. doi: 10.1128/JCM.00646-10. Epub 2010 Jul 7.

48.

Genomic events contributing to the high prevalence of amantadine-resistant influenza A/H3N2.

Zaraket H, Saito R, Suzuki Y, Suzuki Y, Caperig-Dapat I, Dapat C, Shabana II, Baranovich T, Suzuki H.

Antivir Ther. 2010;15(3):307-19. doi: 10.3851/IMP1538.

PMID:
20516551
49.

Antiviral drug susceptibilities of seasonal human influenza viruses in Lebanon, 2008-09 season.

Zaraket H, Saito R, Wakim R, Tabet C, Medlej F, Reda M, Baranovich T, Suzuki Y, Dapat C, Caperig-Dapat I, Dbaibo GS, Suzuki H.

J Med Virol. 2010 Jul;82(7):1224-8. doi: 10.1002/jmv.21795.

PMID:
20513088
50.

Reduced effectiveness of oseltamivir in children infected with oseltamivir-resistant influenza A (H1N1) viruses with His275Tyr mutation.

Saito R, Sato I, Suzuki Y, Baranovich T, Matsuda R, Ishitani N, Dapat C, Dapat IC, Zaraket H, Oguma T, Suzuki H.

Pediatr Infect Dis J. 2010 Oct;29(10):898-904. doi: 10.1097/INF.0b013e3181de9d24.

PMID:
20442686

Supplemental Content

Loading ...
Support Center